Skip to main content
Caplight Logo









Viscient Bio Inc

Viscient Bio Inc

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://www.viscientbiosciences.com/

Last Round

Convertible Debt

Sep 15, 2021

Total Funding Raised

$1M

Company Overview

Viscient Bio Inc is a biotechnology company that develops novel therapies for liver diseases using proprietary 3D human tissue models.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

3D bioprintinghuman tissue modelsdrug discoveryin vitro modelingorgan-on-a-chipdisease modelingpreclinical researchMASHNASHphenotypic analysistherapeutic developmentanimal-free testingbiotech servicestarget validationnew approach methodologiesNAMs

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Viscient Bio Inc Comparables

Compare Viscient Bio Inc with similar companies based on industry and business-model similarity.

Viscient Bio Inc comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VivoSim Labs, Inc.
82%
VoxCell BioInnovation
81%
InSphero
80%

Viscient Bio Inc Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Convertible DebtSep 15, 2021
Convertible DebtMay 30, 2019

Key People

Founding team and executive leadership

Jeffrey N Miner

Co-Founder And Chief Scientific Officer

Founding Team

Keith Murphy

CEO And Founder

Founding Team

Viscient Bio Inc Investors

Notable investors and investment history

Viscient Bio Inc investors
InvestorRounds
SternAegis VenturesConvertible Debt
Thynk CapitalConvertible Debt
Harmonix FundConvertible Debt
Methuselah FoundationConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 30, 2019

    Harmonix Fund, methuselahfund, and Thynk Capital participated.

Viscient Bio Inc Filings

Explore SEC and related filing metadata, where available.

Viscient Bio Inc filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Viscient Bio Inc's valuation, stock price, and market status.

Is Viscient Bio Inc a public or private company?

Viscient Bio Inc is a private company.

What is the current stock price of Viscient Bio Inc?

Viscient Bio Inc is a private company with no public stock price. No recent secondary market data is available.

How much is Viscient Bio Inc worth (valuation)?

Valuation information for Viscient Bio Inc is not publicly available.

Can I buy Viscient Bio Inc stock?

Viscient Bio Inc shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Viscient Bio Inc's last funding round?

Viscient Bio Inc's most recent funding round was Convertible Debt on September 15, 2021.

Who are the main investors in Viscient Bio Inc?

Key investors in Viscient Bio Inc include SternAegis Ventures, Thynk Capital, Harmonix Fund, Methuselah Foundation.

Will Viscient Bio Inc IPO soon?

No public IPO plans have been announced for Viscient Bio Inc.

How can I track Viscient Bio Inc secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Viscient Bio Inc's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Diego, California
Employee Range7
Year Founded2017
Last FundingSep 15, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?